IL-6 is known to induce hepatic inflammatory cell infiltration [33], while PNPLA3 represents a modifier of progression of hepatocellular injury and liver-associated disorders such as steatohepatitis, chronic hepatitis, and hepatocellular carcinoma by promoting the release of inflammatory cytokines [34,35]. This evidence concerns the gene PNPLA3 and chronic hepatitis.